PML and acute promyelocytic leukemia: Arsenic trioxide (ATO), a curative targeted therapy of APL, directly binds PML to enforce NB formation by promoting PML oxidation and multimerization (Jeanne et al., 2010; Zhang et al., 2010; Zhu et al., 1997).